Research-Grade Peptide
CJC-1295 (without DAC)
A GHRH analogue without Drug Affinity Complex, also called Mod GRF 1-29, studied in GH-release signalling research.
3 in stock
- ✓ ≥ 99% purity by HPLC
- ✓ Third-party tested in Canada, COA on every batch
- ✓ Discreet, tracked shipping · free over $250
A GHRH analogue without Drug Affinity Complex, also called Mod GRF 1-29, studied in GH-release signalling research.
Further reading: CJC-1295 (without DAC) on The Peptide Guide — an independent Canadian reference with compound profiles and a reconstitution calculator. Educational only; nothing there is a statement about this product.
Research background
CJC-1295 without DAC — also known as Modified GRF (1-29) — is a shortened, stabilised analogue of growth-hormone-releasing hormone comprising the first 29 amino acids, with substitutions that resist enzymatic degradation. Without the albumin-binding DAC modification it has a much shorter half-life than its counterpart, which is why the two are studied separately: research comparing them typically concerns pulsatile versus sustained receptor signalling. Evidence is preclinical. Research Use Only. Not for human or veterinary use.
Supplied as a lyophilised powder for laboratory research use only. Any context described above refers to published preclinical or in-vitro research — not to human or veterinary use.